SCHEMBL9535546

SCHEMBL9535546

CCc1cn(CCc2ccccc2)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 7/20 0.52
AGTR2 P50052 7/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9036200 0.94 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL9534471 0.92 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9034800 0.92 AGTR1 (0.63) AGTR1AGTR2
SCHEMBL9532721 0.92 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL9530381 0.91 AGTR1 (0.60) AGTR1AGTR2
SCHEMBL9554429 0.90 AGTR1 (0.59) AGTR1AGTR2
SCHEMBL9532990 0.90 AGTR1 (0.48) AGTR1AGTR2
SCHEMBL9553981 0.90 AGTR1 (0.62) AGTR1AGTR2
SCHEMBL9534545 0.89 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9529789 0.89 AGTR1 (0.49) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed